Market Place
Sourcing Support
SCG Cell Therapy`s SCG101V IND Cleared by China NMPA
07 Jul 2025 //
PR NEWSWIRE
SCG presents SCG101 data in HBV-related liver cancer at EASL 2025
07 May 2025 //
PR NEWSWIRE
SCG Cell Therapy Presents Ph 1 Data for HBV-Specific TCR-T Therapy
24 Nov 2024 //
PR NEWSWIRE
SCG Cell Therapy Announces FDA IND Clearance Of SCG142 For HPV-Associated Tumors
30 Jun 2024 //
PR NEWSWIRE
EASL: SCG101 T-Cell Therapy Improved HCC Survival With Chronic HBV
07 Jun 2024 //
PR NEWSWIRE
SCG Cell Therapy Announces Data at AASLD Showing SCG101 Improved Tumor Reponse
13 Nov 2023 //
PR NEWSWIRE
SCG to Present Late-Breaking Data at ISCT Highlighting SCG101
23 Apr 2023 //
PR NEWSWIRE
SCG Cell Therapy to establish research & manufacturing hub in Singapore
21 Sep 2022 //
BIOSPECTRUMASIA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.